Cl-Pharm-IBS-ML-2026

ConditionIBS
Trial statusNot yet recruiting
Trial phaseNot listed
Trial typeObservational
Biological sexAll
Age18-65
SponsorTanta University

About this trial

The purpose of this study is to identify distinct subgroups (phenotypes) of Irritable Bowel Syndrome (IBS) patients. While traditional IBS classification relies mainly on bowel habits, this research uses a multidimensional questionnaire to capture clinical symptoms, psychological factors, diet triggers, sleep quality, and digital behaviors. By applying advanced machine learning algorithms to these patient-reported outcomes, the study aims to uncover hidden patterns that can help customize future treatments and improve patient care.

Eligibility criteria

This trial does not accept healthy volunteers

Qualifiers

Participants aged 18 years or older.

Formal physician-confirmed diagnosis of Irritable Bowel Syndrome (IBS).

Ability to access and complete the digital multidimensional questionnaire.

Willingness to provide digital informed consent.

Disqualifiers

Presence of organic gastrointestinal diseases (e.g., Inflammatory Bowel Disease, celiac disease, or colorectal cancer).

Presence of alarm/red flag symptoms (e.g., nocturnal symptoms waking the patient).

Incomplete or inconsistent questionnaire responses.

Trial population

A convenience sample of adult patients with a physician-confirmed diagnosis of Irritable Bowel Syndrome (IBS) recruited from online health communities, clinical networks, and social media platforms. The population includes individuals across various demographic backgrounds, IBS subtypes, and symptom severity levels, who are capable of completing a digital questionnaire regarding their clinical and lifestyle characteristics.

Trial design

Design model

Other

Time perspective

Cross-sectional

Treatments tested in this trial

  • Questionnaire and Physical Exam

    Other intervention

    ONLINE QUESTIONNAIRE

Treatment groups

No treatment groups listed

Trial outcomes

Primary outcomes

1

Distinct patient subgroups (phenotypes) identified through unsupervised machine learning clustering algorithms.

Time frame
At the time of questionnaire completion (Baseline)

Secondary outcomes

Other outcomes

Locations

This trial has no locations.

Sponsors and contacts

Click on the lead sponsor to view all of their trials.

This trial is not recruiting at the moment. You can still explore other options: